Li, W., August, K. J., Hall, E. M., Yin, D. E., Goyal, R. K., Ahmed, A. A., . . . Myers, G. D. (2021). Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. BMJ Publishing Group.
Cita Chicago Style (17a ed.)Li, Weijie, et al. Tisagenlecleucel Infusion in Patients with Relapsed/refractory ALL and Concurrent Serious Infection. BMJ Publishing Group, 2021.
Cita MLA (8a ed.)Li, Weijie, et al. Tisagenlecleucel Infusion in Patients with Relapsed/refractory ALL and Concurrent Serious Infection. BMJ Publishing Group, 2021.
Precaución: Estas citas no son 100% exactas.